RB
Ranju Bansal
About Ranju Bansal
Data last updated:
Ranju Bansal is a Director at Rrs Pharma & Surgical Twin Private Limited (since 2011) and Director at Aventure Pharma Private Limited (since 2011). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.55 Cr; the largest is Rrs Pharma & Surgical Twin Private Limited at ₹2.57 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Feb 2011 | 2011 | ₹2.57 Cr (FY 2025) | Active | |
| Director | 28 Jun 2011 | 2008 | ₹1.98 Cr (FY 2025) | Active |
Board colleagues of Ranju Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anju Mehra | 03257190 | Rrs Pharma & Surgical Twin Private Limited | Director |
| Rajni Bansal | 00073162 | Rrs Pharma & Surgical Twin Private Limited , Aventure Pharma Private Limited | Director |
| Sanjay Bansal | 00073179 | Rrs Pharma & Surgical Twin Private Limited , Aventure Pharma Private Limited | Director |
| Arun Bansal | 00057870 | Aventure Pharma Private Limited | Director |
| Pankaj Mehra | 00259679 | Aventure Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranju Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranju Bansal
Ranju Bansal currently holds 2 directorships: Rrs Pharma & Surgical Twin Private Limited (Director, since 24 Feb 2011, revenue ₹2.57 Cr (FY 2025)); Aventure Pharma Private Limited (Director, since 28 Jun 2011, revenue ₹1.98 Cr (FY 2025)).
Ranju Bansal was first appointed on 24 Feb 2011 as Director at Rrs Pharma & Surgical Twin Private Limited.
The 2 current companies of Ranju Bansal that report revenue have a combined latest revenue of ₹4.55 Cr: Rrs Pharma & Surgical Twin Private Limited ₹2.57 Cr (FY 2025); Aventure Pharma Private Limited ₹1.98 Cr (FY 2025).
The current boards of Ranju Bansal's companies include Anju Mehra (Rrs Pharma & Surgical Twin Private Limited), Rajni Bansal (Rrs Pharma & Surgical Twin Private Limited), Sanjay Bansal (Rrs Pharma & Surgical Twin Private Limited), Arun Bansal (Aventure Pharma Private Limited), Pankaj Mehra (Aventure Pharma Private Limited).